China Hepatitis Drugs Market Review by AMID Now Available at MarketPublishers.com

Share Article

Most recent report “Chinese Markets for Hepatitis Drugs” worked out by Asia Market Information & Development Co. (AMID) has been recently published by Market Publishers Ltd. The report reveals that over the last ten years China's demand for hepatitis drugs has grown at a fast pace and in the next five years, both production and demand are expected to keep on growing.

TD The Market Publishers Ltd

http://marketpublishers.com/

Over the last ten years China's demand for hepatitis drugs has grown at a fast pace. In the next five years, both production and demand are expected to keep on growing. Because treatment with nucleoside/nucleotide analogues is typically long-term (in many cases, lifelong), even steady diagnosis and drug-treatment rates would generate sizable near-term expansion of this market. Government-sponsored improvements to the healthcare system and increasing economic prosperity among the Chinese population have also added to this market growth.

Most recent report “Chinese Markets for Hepatitis Drugs” worked out by Asia Market Information & Development Co. (AMID) has been recently published by Market Publishers Ltd.

Report Details:

Title: Chinese Markets for Hepatitis Drugs
Published: April, 2012
Pages: 169
Price: US$ 4,000
http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/chinese_markets_4_hepatitis_drugs.html

The research report provides true and unprejudiced insights into the hepatitis drugs market in China. It examines a number of key issues including the country’s economic trends, investment environment, industry development, supply and demand, industry capacity and structure, marketing channels and major industry participants. Furthermore, historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021; as well as elaborate profiles of top producers of hepatitis drugs in China are also available.

Report Contents:

I. Introduction

Report Scope and Methodology
Executive Summary

II. Business Environment

Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. Hepatitis Drugs Industry Assessments

Hepatitis Drugs Industry Structure
Market Size
Market Growth Drivers
Hepatitis Drugs Industry Sales Volumes
Major Producer Facility Locations and Sales Volumes
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development

IV. Hepatitis Drugs Production and Demand

Overview
Sales Volumes of Hepatitis Drugs by Region in 2011
Hepatitis Drugs Sales Volumes
Liver Protection Drugs
Nucleoside Drugs
Interferon (IFN)
Other Hepatitis Drugs
Hepatitis Drugs Imports and Exports
Hepatitis Drugs Imports
Hepatitis Drugs Exports
Pricing Trend

V. Hepatitis Drugs Market Outlook

Hepatitis Drugs Market Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. Marketing Strategies

China Market Entry Overview
China’s Distribution System
Hepatitis Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
China’s Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
...

More new market research reports by the publisher can be found at AMID page.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tanya Rezler
Visit website